Cargando…

Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma

PURPOSE: We developed a novel inflammation-based model (NPS), which consisted of a neutrophil to lymphocyte ratio (NLR) and platelet count (PC), for assessing the prognostic role in patients with metastatic urothelial carcinoma (UC). MATERIALS AND METHODS: We performed a retrospective analysis of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yu-Li, Hsieh, Meng-Che, Chiang, Po-Hui, Sung, Ming-Tse, Lan, Jui, Luo, Hao-Lun, Huang, Chun-Chieh, Huang, Cheng-Hua, Tang, Yeh, Rau, Kun-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226814/ https://www.ncbi.nlm.nih.gov/pubmed/28076369 http://dx.doi.org/10.1371/journal.pone.0169657

Ejemplares similares

Impact of Prognostic Nutritional Index on Overall Survival for Patients with Metastatic Urothelial Carcinoma
por: Hsieh, Meng-Che, et al.
Publicado: (2018)

A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy
por: Hsieh, Meng-Che, et al.
Publicado: (2016)

The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma
por: Hsieh, Meng-Che, et al.
Publicado: (2015)

Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder
por: Hsieh, Meng-Che, et al.
Publicado: (2016)

Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
por: Huang, Hui-Shan, et al.
Publicado: (2018)

The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy
por: Tsai, Tsung-Han, et al.
Publicado: (2023)

The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
por: Chang, Yin Lun, et al.
Publicado: (2023)

The Prognostic Impact of Tumor Architecture for Upper Urinary Tract Urothelial Carcinoma: A Propensity Score-Weighted Analysis
por: Liu, Hui-Ying, et al.
Publicado: (2021)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2019)

Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2021)

Comparison of the Prognostic Value of Ki-67 and Programmed Cell Death Ligand-1 in Patients with Upper Tract Urothelial Carcinoma
por: Tsai, Mu-Yao, et al.
Publicado: (2021)

Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
por: Su, Yu-Li, et al.
Publicado: (2020)

The lowest level of tumor involvement is a significant prognostic factor for upper tract urothelial carcinoma after radical nephroureterectomy: A large retrospective cohort study
por: Huang, Ying-Che, et al.
Publicado: (2022)

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy
por: Dionese, Michele, et al.
Publicado: (2023)

Prognostic significance of inflammation-based prognostic scoring in patients with upper urinary tract urothelial carcinoma
por: Suyama, Taisuke, et al.
Publicado: (2019)

Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
por: Kuo, Ming-Chun, et al.
Publicado: (2020)

VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma
por: Luo, Hao-Lun, et al.
Publicado: (2023)

Expression of Estrogen Receptor Beta Predicts Oncologic Outcome of pT3 Upper Urinary Tract Urothelial Carcinoma Better Than Aggressive Pathological Features
por: Luo, Hao Lun, et al.
Publicado: (2016)

A Novel Systemic Inflammation Prognostic Score to Stratify Survival in Elderly Patients With Cancer
por: Ruan, Guo-Tian, et al.
Publicado: (2022)

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma
por: Inamoto, Teruo, et al.
Publicado: (2017)

Aqueous Extract of Descuraniae Semen Attenuates Lipopolysaccharide-Induced Inflammation and Apoptosis by Regulating the Proteasomal Degradation and IRE1α-Dependent Unfolded Protein Response in A549 Cells
por: Hsieh, Po-Chun, et al.
Publicado: (2022)

Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study
por: Huang, Guan-Lin, et al.
Publicado: (2019)

First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis
por: Lin, Chang-Ting, et al.
Publicado: (2022)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

Metastatic urothelial carcinoma()()
por: Gómez-Moyano, Elisabeth, et al.
Publicado: (2021)

Clinical Determinants of Extraurinary Tract Recurrence and Survival after Radical Surgery for pT2 Upper Tract Urothelial Carcinoma
por: Huang, Yun-Ching, et al.
Publicado: (2023)

Predictors of Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: An Inflammation-Based Prognostic Score
por: Cho, Yang Hyun, et al.
Publicado: (2014)

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
por: Murri, A M Al, et al.
Publicado: (2006)

The MicroRNA Prediction Models as Ancillary Diagnosis Biomarkers for Urothelial Carcinoma in Patients With Chronic Kidney Disease
por: Li, An-Lun, et al.
Publicado: (2021)

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process
por: Su, Yu-Li, et al.
Publicado: (2023)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

Propensity-Matched Survival Analysis of Upper Urinary Tract Urothelial Carcinomas between End-Stage Renal Disease with and without Kidney Transplantation
por: Luo, Hao Lun, et al.
Publicado: (2019)

Conditional Survival in de novo Metastatic Urothelial Carcinoma
por: Pal, Sumanta Kumar, et al.
Publicado: (2015)

Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma
por: Yeh, Cheng-Fa, et al.
Publicado: (2021)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

Presence of Chronic Obstructive Pulmonary Disease (COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A Nationwide, Population-Based Cohort Study
por: Wu, Chia-Che, et al.
Publicado: (2019)

Risk Stratification of Upper Urinary Tract Urothelial Carcinoma Patients for Survival Prediction: A Simple Summation Scoring Method
por: Wang, Li-Jen, et al.
Publicado: (2018)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fv2vitutan890u5mppubib2mm6